Evidence map›Paper›PMID 25565358›Full record

ReviewGenes, brain, and behavior2015

Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

T J Phillips, C Reed, R Pastor

Open access · bronzeAbstract readReview
In one paragraph

Review in Genes, brain, and behavior, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Biobehavioral Interactions Between Stress and Alcohol.Alcohol research : current reviews · 2019
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. The GABABrain sciences · 2018
    Article
  12. Central Administration of Cyclosporine A Decreases Ethanol Drinking.Alcohol and alcoholism (Oxford, Oxfordshire) · 2018
    Article
  13. Article
  14. Acupuncture on the Stress-Related Drug Relapse to Seeking.Evidence-based complementary and alternative medicine : eCAM · 2018
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Progress in neuro-psychopharmacology & biological psychiatry · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

T J PhillipsVA Portland Health Care System, Portland Alcohol Research Center, Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR, USA; Department of Behavioral Neuroscience, Portland Alcohol Research Center, Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR, USA.
C Reed
R Pastor
Oregon Health & Science University · US

Funding

Translational measures of risk for excessive alcohol consumptionP60AA010760 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Suzanne S. Fei · 2006 to 2026
$34.5M
Traditional Service Core [Translational Service Core (TSC)]P50DA018165 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 2006 to 2016
$13.0M
Selective Breeding for Drinking in the Circadian DarkU01AA013519 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Angela Renee Ozburn · 2001 to 2026
$10.9M
Mouse Genetic Models for Alcohol ResearchR24AA020245 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI PHILLIPS, TAMARA J. · 2011 to 2020
$2.3M
Genetic Determinants of Drug EffectsI01BX000368 · VA · PORTLAND VA MEDICAL CENTER · PI PHILLIPS, TAMARA J. · 2009 to 2012
–
BLRD VA I01 BX000368BLRD VA IK6 BX006342NIAAA NIH HHS P60 AA010760NIAAA NIH HHS P60AA010760NIAAA NIH HHS R24 AA020245NIAAA NIH HHS R24AA020245NIAAA NIH HHS U01 AA013519NIAAA NIH HHS U01AA013519NIDA NIH HHS P50 DA018165NIDA NIH HHS P50DA018165
6 · The paper itself

Abstract

The results of many studies support the influence of the corticotropin-releasing factor (CRF) system on ethanol (EtOH) consumption and EtOH-induced neuroadaptations that are critical in the addiction process. This review summarizes the preclinical data in this area after first providing an overview of the components of the CRF system. This complex system involves hypothalamic and extra-hypothalamic mechanisms that play a role in the central and peripheral consequences of stressors, including EtOH and other drugs of abuse. In addition, several endogenous ligands and targets make up this system and show differences in their involvement in EtOH drinking and in the effects of chronic or repeated EtOH treatment. In general, genetic and pharmacological approaches paint a consistent picture of the importance of CRF signaling via type 1 CRF receptors (CRF(1)) in EtOH-induced neuroadaptations that result in higher levels of intake, encourage alcohol seeking during abstinence and alter EtOH sensitivity. Furthermore, genetic findings in rodents, non-human primates and humans have provided some evidence of associations of genetic polymorphisms in CRF-related genes with EtOH drinking, although additional data are needed. These results suggest that CRF(1) antagonists have potential as pharmacotherapeutics for alcohol use disorders. However, given the broad and important role of these receptors in adaptation to environmental and other challenges, full antagonist effects may be too profound and consideration should be given to treatments with modulatory effects.

Indexed as

Adaptation, PhysiologicalSignal TransductionAlcohol DrinkingAnimalsCorticotropin-Releasing HormoneHumansReceptors, Corticotropin-Releasing HormoneCorticotropin-Releasing HormoneReceptors, Corticotropin-Releasing HormoneAlcoholalcohol use disorderethanol drinkingethanol seekinggenetic animal modelHPA axisknockoutpharmacologypharmacotherapysensitizationstressurocortin

Identifiers

PMID25565358
PMCPMC4851463
OpenAlexW1522004584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.